Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,698 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Chinese girls and women aged 9 to 45 years, 2018-2020.
Wu Q, Qian M, Welby S, Guignard A, Rosillon D, Gopala K, Xu Y, Liu K, He Y, Jiang N, Tan Q, Xie J, Zhu T, Wang Q, Pan Y, Zeng R, Yang J, Zhao X, Zhou M, Navarro-Torné A, Yu H, Borys D. Wu Q, et al. Among authors: jiang n. Hum Vaccin Immunother. 2023 Dec 15;19(3):2283912. doi: 10.1080/21645515.2023.2283912. Epub 2023 Dec 1. Hum Vaccin Immunother. 2023. PMID: 38038626 Free PMC article.
MOnitoring human papillomavirus Vaccine effect on Infection and cErvical diseases (MOVIE): Protocol for a cohort study using electronic health records from Yinzhou, China.
Deng S, Welby S, Liu Z, Yang Y, Meng R, Sun Y, Yang J, Liu G, He Y, Jiang N, Wu Z, Liu K, Rosillon D, Cohet C, Borys D, Zhan S. Deng S, et al. Among authors: jiang n. Hum Vaccin Immunother. 2023 Aug;19(2):2257989. doi: 10.1080/21645515.2023.2257989. Epub 2023 Oct 9. Hum Vaccin Immunother. 2023. PMID: 37813849 Free PMC article.
The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials.
Kim JH, Diaz-Decaro J, Jiang N, Hwang SJ, Choo EJ, Co M, Hastie A, Hui DSC, Irimajiri J, Lee J, Leung EM, Tang H, Tsuru T, Watson P, Wu Z, Yu CJ, Yuan Y, Zahaf T, Cunningham AL, Schuind A. Kim JH, et al. Among authors: jiang n. Hum Vaccin Immunother. 2021 Jul 3;17(7):2050-2057. doi: 10.1080/21645515.2020.1859321. Epub 2021 Feb 19. Hum Vaccin Immunother. 2021. PMID: 33606577 Free PMC article.
Lifetime risk of herpes zoster in the population of Beijing, China.
Lee C, Giannelos N, Curran D, Dong H, Tang H, Jiang N, Ye C, Yuan Y, Ng C. Lee C, et al. Among authors: jiang n. Public Health Pract (Oxf). 2023 Jan 10;5:100356. doi: 10.1016/j.puhip.2023.100356. eCollection 2023 Jun. Public Health Pract (Oxf). 2023. PMID: 36968763 Free PMC article.
A systematic literature review to assess the burden of herpes zoster disease in China.
Yin D, Van Oorschot D, Jiang N, Marijam A, Saha D, Wu Z, Tang H, Diaz-Decaro J, Watson P, Xie X, Ren Y, He Y, Feng Y. Yin D, et al. Among authors: jiang n. Expert Rev Anti Infect Ther. 2021 Feb;19(2):165-179. doi: 10.1080/14787210.2020.1792290. Epub 2020 Sep 30. Expert Rev Anti Infect Ther. 2021. PMID: 32997550
4,698 results